APM
Avidity Partners Management Portfolio holdings
AUM
$499M
This Quarter Return
-1.01%
1 Year Return
+3.47%
3 Year Return
+181.12%
5 Year Return
+409%
10 Year Return
–
AUM
$4.36B
AUM Growth
+$4.36B
(-3.3%)
Cap. Flow
+$173M
Cap. Flow
% of AUM
3.97%
Top 10 Holdings %
Top 10 Hldgs %
45.02%
Holding
102
New
10
Increased
31
Reduced
13
Closed
19
Top Buys
| 1 |
Eli Lilly
LLY
|
$198M |
| 2 |
argenx
ARGX
|
$150M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$107M |
| 4 |
Humana
HUM
|
$99.9M |
| 5 |
Johnson & Johnson
JNJ
|
$97M |
Top Sells
| 1 |
Merck
MRK
|
$194M |
| 2 |
Baxter International
BAX
|
$149M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$146M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$115M |
| 5 |
AbbVie
ABBV
|
$109M |
Sector Composition
| 1 | Healthcare | 95.35% |
| 2 | Financials | 0.54% |
| 3 | Technology | 0.11% |